Becton Dickinson (BDX) Return on Assets ROA from the third quarter of 2026 to third quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Becton Dickinson And Company  (NYSE: BDX)


Becton Dickinson's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Becton Dickinson's ROA in the third quarter of 2026?
Becton Dickinson And Company achieved a return on average assets (ROA) of 1.61 % in its third quarter of 2026, which is below Becton Dickinson's average return on assets, which stands at 6.94%.

ROA fell compared to the second quarter of 2026, despite the net income growth of % from the second quarter of 2026.

However, within the Healthcare sector 194 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 1803, from total ROA ranking in the second quarter of 2026 at 1816.

What is ROA?



Return On Assets (Jun 30 2026)
III. Quarter
(Mar 31 2026)
II. Quarter
(Dec 31 2025)
I. Quarter
(Sep 30 2025)
IV. Quarter
(Jun 30 2025)
III. Quarter
Y / Y Total Assets Change -5.47 % -6.93 % 11.65 % 38.48 % -0.99 %
Y / Y Net Income Change -34.32 % - 26.07 % 23.25 % 17.86 %
Net Income (TTM) in million 941 1,138 1,757 1,678 1,585
Return On Assets (TTM) 1.61 % 1.92 % 2.91 % 2.85 % 2.93 %
BDX's Total Ranking # 1803 # 1816 # 1590 # 1614 # 1671
Total Assets (TTM) in million 55,707 54,435 55,325 68,622 58,933
Seq. Total Assets Change 2.34 % -1.61 % -19.38 % 16.44 % 0.76 %
Seq. Net Income Change - - -22.52 % -14.11 % 86.36 %



Return On Assets Company Ranking
Within: No.
Industry # 61
Sector # 195
Overall # 1873

Return On Assets Statistics
High Average Low
14.93 %
6.94 %
0.11 %
(June 30. 2009)   (Mar 31 2018)





Financial Statements
Becton Dickinson's Assets $ 55,707 million BDX's Balance sheet
Becton Dickinson's Income $ 377 million Quarterly BDX's Income Statement
BDX's Income by Division See BDX's Income by Division



Annual Return On Assets (Sep 30 2025)
FY 2025
(Sep 30 2024)
FY 2024
(Sep 30 2023)
FY 2023
(Sep 30 2022)
FY 2022
(Sep 30 2021)
FY 2021
Y / Y Total Assets Change -1.77 % 10.8 % 2.04 % -1.4 % 1.33 %
Total Assets in million 48,674 49,553 44,722 43,826 44,449
Y / Y Net Income Change -1.58 % 14.89 % -16.58 % -14.96 % 139.36 %
Net Income in million 1,678 1,705 1,484 1,779 2,092
Annual Return On Assets 3.45 % 3.44 % 3.32 % 4.06 % 4.71 %




Comment on BDX's ROA in the fiscal year ending 2025
Despite deterioration in net income of -1.58 % to $1,678.00 million, Becton Dickinson's ROA improved in the fiscal year2025 to 3.45 % compared to previous year, as the value of BDX's assets decline even faster to $48,674.00 million, from $48,674.00 a year before.


More Return On Assets Ratios
BDX's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
BDX's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for BDX's Competitors
Subscribers only: Roa for Becton Dickinson's Suppliers
Subscribers only: Return On Assets for BDX's Customers

You may also want to know
BDX's Roi BDX's Inventory Turnover Ratio BDX's Growth Rates BDX's Dividend Comparisons
BDX's Profitability Ratios BDX's Asset Turnover Ratio BDX's Dividend Growth
BDX's Roe BDX's Valuation Ratios BDX's Financial Strength Ratios BDX's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA
Nrc Health  4.31 %
Cadre Holdings inc   4.29 %
The Pennant Group Inc   4.14 %
U S Physical Therapy Inc  4.08 %
Haemonetics Corporation  3.99 %
Henry Schein Inc   3.79 %
Integer Holdings Corporation  3.76 %
Zimmer Biomet Holdings Inc   3.51 %
Ardent Health Inc   3.22 %
Community Health Systems Inc   3.17 %
Vaso Corporation  2.92 %
Collegium Pharmaceutical Inc   2.72 %
National Vision Holdings Inc   2.53 %
Conmed Corporation  2.44 %
Merck and Co Inc   2.42 %
Privia Health Group Inc   2.41 %
Lifestance Health Group Inc   2.33 %
Bio rad Laboratories Inc   2.21 %
Pfizer Inc  2.12 %
Mimedx Group Inc   1.99 %
Revvity Inc  1.97 %
Alkermes Plc   1.96 %
Becton Dickinson And Company  1.77 %
Teva Pharmaceutical Industries Limited  1.77 %
Immucell Corporation  1.76 %
Envista Holdings Corporation  1.69 %
Atricure Inc   1.62 %
Black Hawk Acquisition Corporation  1.56 %
Repligen Corp  1.41 %
Omada Health Inc   1.41 %


Date modified: 2026-09-08T15:11:45+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.